Potentiation of antiaggregating effect of prostaglandins by alpha-tocopherol and quercetin

Platelets
V MardlaNigulas Samel

Abstract

Prostaglandin (PG) I2 (prostacyclin), PGE1 and their analogues are effective inhibitors of platelet aggregation. However, a clinical use of these compounds for the treatment of cardiovascular diseases is restricted due to unwanted side effects. Alpha-tocopherol and quercetin are weak antiplatelet agents. At the same time, they have mild if any side effects when consumed medicinally. The aim of this work was to study the possibility to decrease the effective antiplatelet concentrations of PGs combining them with alpha-tocopherol or quercetin. Platelet-rich plasma (PRP) was prepared from human blood. The inhibition of adenosine diphosphate-induced platelet aggregation was caused by PGs in the presence and absence of alpha-tocopherol or quercetin and corresponding concentration-effect curves were obtained. At a subthreshold concentration 200 and 2 microM, respectively, both alpha-tocopherol and quercetin essentially increased the antiplatelet effects of PGI2, PGE1 and iloprost. Especially effective was the combination of alpha-tocopherol with low concentrations of iloprost. Thus, combination of PGs with alpha-tocopherol or quercetin allows the use of prostaglandins at lower concentrations to inhibit platelet aggregation.

References

Mar 1, 1976·The Journal of Clinical Investigation·M Steiner, J Anastasi
Oct 1, 1991·Thrombosis Research·S H TzengC M Teng
Jan 1, 1996·Trends in Pharmacological Sciences·H Wise, R L Jones
Dec 1, 1995·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·J V Formica, W Regelson
Aug 13, 1998·The American Journal of Clinical Nutrition·S N MeydaniE J Schaefer
Apr 1, 1999·European Journal of Clinical Nutrition·G T McAnlisI S Young
Apr 22, 1999·General Pharmacology·L Gamet-PayrastreB Payrastre
Oct 16, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·P PignatelliF Violi
Nov 14, 2001·Biochemical Pharmacology·U R SchwarzM Eigenthaler
Apr 12, 2002·Current Medicinal Chemistry·Jean-Michel DogneJean-Louis David
Jan 30, 2003·Clinical Biochemistry·David M GoldbergGeorge J Soleas
Oct 31, 2003·Molecular Aspects of Medicine·A AzziJ-M Zingg

❮ Previous
Next ❯

Citations

May 19, 2005·Biological Chemistry·Mirta SchattnerAna Marisa Chudzinski-Tavassi
Jun 21, 2005·Biochemical and Biophysical Research Communications·Márcio FritzenAna Marisa Chudzinski-Tavassi
Aug 1, 2006·Pathophysiology of Haemostasis and Thrombosis·Suzanne J A Korporaal, Jan-Willem N Akkerman
Oct 2, 2008·Current Opinion in Clinical Nutrition and Metabolic Care·Stephan C Bischoff
Aug 20, 2019·Platelets·Gennadi Kobzar
May 14, 2021·Critical Reviews in Food Science and Nutrition·Javad Sharifi-RadDaniela Calina

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.